Glucosyl-C18-sphingosine
| Catalog Number | BL-M001142 |
| CAS Number | 52050-17-6 |
| Description | Glucosyl-C18-sphingosine is a cytotoxic compound. Accumulation of Glucosyl-C18-sphingosine in brain and other tissues occurs in patients with Gaucher disease, which is an inherited deficiency of lysosomal glucocerebrosidase, which converts glucosylsphingosine to glucose and sphingosine. |
 | |
| IUPAC Name | (2R,3R,4S,5S,6R)-2-[(E,2S,3R)-2-amino-3-hydroxyoctadec-4-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| Synonyms | glucosylsphingosine; Lyso GlcCer; lyso-GlcCer; D-Glucosylsphingosine; Glucosyl sphingosine; beta-D-glucosylsphingosine; 1-glucosyl-sphing-4-enine; Glucosyl(β) Sphingosine (d18:1); (2S,3R,4E)-1-O-beta-(D-glucopyranosyl)-4-sphingenine |
| Molecular Weight | 461.63 |
| Molecular Formula | C24H47NO7 |
| Boiling Point | >300°C at 760 mmHg |
| Purity | >99% |
| Solubility | Soluble in chloroform/methanol(4:1). |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 62.44%, H 10.26%, N 3.03%, O 24.26% |
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)N)O |
| InChI | InChI=1S/C24H47NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(27)18(25)17-31-24-23(30)22(29)21(28)20(16-26)32-24/h14-15,18-24,26-30H,2-13,16-17,25H2,1H3/b15-14+/t18-,19+,20+,21+,22-,23+,24+/m0/s1 |
| InChI Key | HHJTWTPUPVQKNA-JIAPQYILSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
